Log In
Print
BCIQ
Print
Print this Print this
 

ITI-007 (formerly ITI-722)

Also known as: Low-dose ITI-007

  Manage Alerts
Collapse Summary General Information
Company Intra-Cellular Therapies Inc.
DescriptionDual serotonin (5-HT2A) receptor antagonist and dopamine receptor phosphoprotein modulator (DPPM)
Molecular Target Serotonin (5-HT2A) receptor ; Dopamine D2 receptor
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today